Mechanistic description
Small molecules or peptides targeting the IDRs of toxic aggregation-prone proteins could prevent their aberrant recruitment into phase-separated condensates.
Debate provenance: derived from debate sess_SDA-2026-04-08-gap-pubmed-20260406-062229-3ab00c95 on question: While the study shows 53BP1 forms phase-separated foci driven by dilncRNAs, it’s unclear what molecular features determine which DDR proteins are selectively recruited versus excluded from these condensates. This selectivity mechanism could be relevant to protein aggregation diseases where specific . Consensus signal: clinical_trialist, domain_expert, skeptic, synthesizer, theorist discussed the mechanism terms Competition, IDR, MAPT, aggregation. Novelty signal: skeptic-discussed-with-qualified-concession.
Evidence for (1)
Evidence matrix
Cite this hypothesis
Cite this hypothesis
etl-backfill (2026). IDR Competition Therapy. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-debate-fbca3a2cb8ee
@misc{scidex_hypothesis_hdebatef,
title = {IDR Competition Therapy},
author = {etl-backfill},
year = {2026},
howpublished = {SciDEX hypothesis},
url = {https://prism.scidex.ai/hypotheses/h-debate-fbca3a2cb8ee},
note = {SciDEX artifact hypothesis:h-debate-fbca3a2cb8ee}
}